Matches in Wikidata for { <http://www.wikidata.org/entity/Q60622762> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q60622762 description "artículu científicu espublizáu n'abril de 2017" @default.
- Q60622762 description "im April 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60622762 description "scientific article published on 29 April 2017" @default.
- Q60622762 description "wetenschappelijk artikel" @default.
- Q60622762 description "наукова стаття, опублікована в серпні 2017" @default.
- Q60622762 name "Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta" @default.
- Q60622762 name "Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta" @default.
- Q60622762 type Item @default.
- Q60622762 label "Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta" @default.
- Q60622762 label "Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta" @default.
- Q60622762 prefLabel "Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta" @default.
- Q60622762 prefLabel "Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta" @default.
- Q60622762 P1433 Q60622762-28813E5B-0A4F-47AD-9549-C72593C8E54A @default.
- Q60622762 P1476 Q60622762-DA660ECA-B91C-4788-AC4D-7CDFD10EDFB9 @default.
- Q60622762 P2093 Q60622762-0FAA4243-6037-496F-BDE2-D416480D19FD @default.
- Q60622762 P2093 Q60622762-24FD55AC-8BD8-4829-9A96-26EA4296B6D0 @default.
- Q60622762 P2093 Q60622762-339A5B9E-5A6E-4480-A35F-14DD3D450A3B @default.
- Q60622762 P2093 Q60622762-A4DF7D2C-CB9E-4974-AE0A-5A01038CE7FB @default.
- Q60622762 P2093 Q60622762-AEB49F48-0AE4-4113-86B4-962C9FCFDEBB @default.
- Q60622762 P2093 Q60622762-B5DF99AA-0122-4486-8CCC-6148D47391C4 @default.
- Q60622762 P2093 Q60622762-D23D424E-C3F0-4BCC-B2C8-C5A809813167 @default.
- Q60622762 P304 Q60622762-F718EFCC-DC0F-4E01-8ED4-204340DE19D8 @default.
- Q60622762 P31 Q60622762-5379B8D0-AD61-426E-973A-299F0197CFF1 @default.
- Q60622762 P356 Q60622762-790D6ED1-B559-4680-BDA8-DA3CD43156FA @default.
- Q60622762 P478 Q60622762-764FB300-F11B-41B5-AA14-BADD3C56C9E8 @default.
- Q60622762 P50 Q60622762-C77C92C3-3E32-4115-90D0-3790E1E1AF28 @default.
- Q60622762 P577 Q60622762-BA8F9518-7535-4B1E-BE50-1F3882F45EB7 @default.
- Q60622762 P698 Q60622762-C7C45E95-E4FB-42B2-A217-F40A5A67D501 @default.
- Q60622762 P921 Q60622762-1F321EDE-F4A5-4B7E-BB89-5D4A010107B8 @default.
- Q60622762 P921 Q60622762-7CE462E8-D652-4315-BBB8-9A4413DA2B94 @default.
- Q60622762 P356 J.BONE.2017.04.016 @default.
- Q60622762 P698 28461254 @default.
- Q60622762 P1433 Q15755003 @default.
- Q60622762 P1476 "Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta" @default.
- Q60622762 P2093 "Aaron Schindeler" @default.
- Q60622762 P2093 "Craig Munns" @default.
- Q60622762 P2093 "David G Little" @default.
- Q60622762 P2093 "Ina Kramer" @default.
- Q60622762 P2093 "Kathy Mikulec" @default.
- Q60622762 P2093 "Lauren Peacock" @default.
- Q60622762 P2093 "Michaela Kneissel" @default.
- Q60622762 P304 "96-103" @default.
- Q60622762 P31 Q13442814 @default.
- Q60622762 P356 "10.1016/J.BONE.2017.04.016" @default.
- Q60622762 P478 "101" @default.
- Q60622762 P50 Q41475163 @default.
- Q60622762 P577 "2017-04-29T00:00:00Z" @default.
- Q60622762 P698 "28461254" @default.
- Q60622762 P921 Q218507 @default.
- Q60622762 P921 Q749409 @default.